Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / CL A
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
11,466,013
-
Shares change
-
+257,265
-
Total reported value, excl. options
-
$235,163,235
-
Value change
-
+$3,997,088
-
Put/Call ratio
-
68.1%
-
Number of buys
-
41
-
Number of sells
-
-31
-
Price
-
$20.51
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2018
100 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q1 2018.
REATA PHARMACEUTICALS INC - CL A (RETA) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,466,013 shares
.
Largest 10 shareholders include CPMG Inc (2,912,523 shares), BlackRock Inc. (1,191,784 shares), FMR LLC (629,851 shares), VANGUARD GROUP INC (624,674 shares), EMERALD ADVISERS INC/PA (493,753 shares), EMERALD MUTUAL FUND ADVISERS TRUST (471,114 shares), Cormorant Asset Management, LP (450,000 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (390,000 shares), Boxer Capital, LLC (325,000 shares), and Prosight Management, LP (297,750 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.